
Onkolyze offers AI-powered solutions for personalized cancer treatment. Their product suite includes DicommAnon for anonymizing DICOM images, classification and segmentation algorithms to identify and segment regions of interest in medical images, and medical annotation software/service for expert radiologist annotations. They leverage machine learning, complexity science, and computational fluid dynamics to provide tools that enhance cancer care personalization. The company also engages in applied deep learning research, chemotherapeutic drug efficacy studies, and mathematical modeling of tumors.

Onkolyze offers AI-powered solutions for personalized cancer treatment. Their product suite includes DicommAnon for anonymizing DICOM images, classification and segmentation algorithms to identify and segment regions of interest in medical images, and medical annotation software/service for expert radiologist annotations. They leverage machine learning, complexity science, and computational fluid dynamics to provide tools that enhance cancer care personalization. The company also engages in applied deep learning research, chemotherapeutic drug efficacy studies, and mathematical modeling of tumors.